Proteomics Conferences 2018 | Molecular Medicine Congress …

Welcome Message

On behalf of the Scientific Committee, we are honored to invite you to12thInternational Conference and Expo on Proteomics and Molecular Medicineto be held inDublin, IrelandduringNovember 26-28, 2018.

The Theme of theProteomics and Molecular Medicine 2018is Solving problems in Proteomics, Biology and Medicine” which covers wide range of critically important sessions in the field of Proteomics, Molecular Medicine, Mass Spectrometry, Protein Analysis, Biochemistry, Bioinformatics, Molecular Diagnostics, Molecular Devices, Molecular Biology and Pathology. Objective of this meeting is to share the foremost updated knowledge in the field of proteomics, drug discovery, development and diagnostics. We will gather academicians and young inspired scientists from all around the world involved in researches at the cutting edge in the study of the proteomics and molecular medicine.

The conference proceedings will include Keynote/plenary Sessions, Oral Presentations, Seminars, Symposiums, Workshops, Young Researchers Forums and Posters Presentations on the latest treatment innovations in the field ofMolecular Medicine,Diagnostics and the advancements in Proteomics, BioinformaticsandMass spectrometryby experts from both academic and business background.

It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Proteomics and Molecular Medicine.

Proteomics and Molecular Medicine 2018committed to create real and reliable contributions to the scientific community.Conference Series llc LTDorganize 2000+ Conferences once a year across USA, Canada , Europe, Middle East & Asia with support from a thousand additional scientific societies and Publishes 900+ Open access journals that contains over thousands eminent personalities, putative scientists as editorial board members.

Why to attend??

Encounter the target market with members from across the globe, committed to learn about Proteomics and Molecular Medicine. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about Proteomics and Molecular Medicine and receive name recognition at this 3-days event. World-eminent speakers, most recent researches, latest treatment techniques and theadvanced updates in protein analysis, mass spectrometry, molecular diagnostics and devices are the principal features of this conference.

Target Audience:

Our Organization would be privileged to welcome the:

Highlights of latest advances on Proteomics and Molecular Medicine 2018

Track: 1Proteomics from Discovery to Function

Proteomicsis an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. When genes are disrupted, theproteinsare also affected. Whenpathogensinfect us, causing disease, proteins play a key role in signaling the presence and ridding us of these invaders. Almost every process that occurs in our cells from the metabolization of simple sugar to the division of cells is dependent on proteins for smooth operation. In general,proteomicsseeks to detect and quantify as many proteins as possible.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 2Mass Spectrometry in Proteome Research

Mass spectrometry(MS) – based proteomics allows the sensitive and accurate quantification of almost complete proteomes of complex biological fluids and tissues. At the moment, however, the routinely usage of MS-based proteomics is prevented and complicated by the very complex work flow comprising sample preparation,chromatography, MS measurement followed by data processing and evaluation. The new technologies, products and assays developed byPrecision Proteomicscould help enabling and establishing mass spectrometry (MS) – based proteomics in academic andpharmaceutical proteomicsresearch as well as in clinical diagnostics.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 3Proteomics and Molecular Medicine

Molecular Medicinepromotes the thoughtful of biological mechanism of disease at the cellular and molecular levels for enhanced diagnoses, treatment, and prevention of disease. Proteomics plays an important role in medical research and molecular medicine, such as in drug discovery anddiagnostics, because of the link between proteins, genes anddiseases, and it is considered to be the next step in modern biology. Proteomics is dynamic compared to genomics because it changes constantly to reflect the cells environment. The main objectives in the arena of proteomics are; identifying all proteins, analyse differentialprotein expressionin different samples, characterise proteins by identifying and studying their function and cellular localisation, and recognize protein interaction networks.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 4Molecular Medicine and Diagnostics

Molecular diagnosticsis prominent disruptive innovation in healthcare by the introduction of many tools that are having a profound impact onhealthcaredelivery. These includenext-generation sequencing, wearable sensors, liquid biopsies, direct-to-consumer testing, point-of-care assays, and early cancer detection. Join industry leaders at the molecular diagnostics event to discuss recent developments and decipher how changes in regulation, reimbursement, and implementation guidelines will impact progress in new markets created by innovations in this technology.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 5Molecular Diagnostics and Devices

Molecular diagnosticsand devices are enabling precise diagnosis and treatment ofoncology, infectious disease and immunotherapy. Experts in the arena will highlight the latest tools, clinical advances, besides commercial applications of circulating and tissue-based biomarkers that are transformingmedicine.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 6Protein Expression and Analysis

Protein expressionrefers to the way in which proteins are synthesized, modified and regulated in living organisms. In protein research, the term can apply to either the object of study or the laboratory techniques required to manufacture proteins.Protein analysisis thebioinformaticsstudy of protein structure,protein interactionand function using database searches, sequence comparisons, structural and functional predictions.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 7Proteomics and its Medicinal Research

Personalised medicineaims to tailor treatments to achieve the best outcome for individual patients, rather than treating patients with a one size fits all approach. Personalized medicine, also termedprecision medicine, is a medical procedure that separates patients into different groupswith medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 8Proteomics in Biochemistry and Molecular Biology

Biochemistryis the study of the structure and function of biological molecules such as proteins, nucleic acids, carbohydrates and lipids. Biochemistry is also used to describe techniques suited to understanding the interactions and functions ofbiological moleculesand it is a laboratory based science that brings together biology and chemistry. By using chemical knowledge and techniques, biochemists can understand and solve biological problems. Biochemistry focuses on processes happening at a molecular level and it focuses on whats happening inside our cells. It also looks at how cells communicate with each other, for example during growth or fighting illness. Medicine is a broad category but relates to biochemistry on many levels. Doctors and nurses give drugs to patients to help cure a disease or prevent it. This is since when thatdrugis added to the human system, it alters how other chemicals in the body function, resulting in disease prevention or recovery.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 9Precision Medicine and Immuno-Oncology

The significance and role of the human genome in thediagnosisand treatment of disease, they lay out the groundwork for precision or genomic medicine. In turn,immuno-oncologyresearches are changing the way we treat cancer by unleashing the immune system, and achieving better survival for many patients and cure for some. Covering latest advances in precision medicine,genomicsand genetics for drug discovery application, cancer immuno-therapy, biomarkers and translational strategies in immune-oncology, Precision Medicine and Immuno-Oncology tracks will bring together uppermost experts from industry and academia to discuss emerging trends and solutions in order to provide the most up-to-date, scientifically sound care for patients with cancer and chronic diseases.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 10Proteomics in Computational Systems Biology

Systems biologyis an exciting new approach to understand biological complexity. It builds on large-scale measurement technologies, such asnext-generation sequencingandmass spectrometry.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Track: 11Proteomics for Bioinformatics

Bioinformaticsis both an umbrella term for the body of biological studies that use computer programming as part of their methodology, as well as a reference to specific analysis “pipelines” that are repeatedly used, particularly in the fields of genetics andgenomics. Common uses ofbioinformaticsinclude the identification of candidate genes and nucleotides.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Human Proteome Organization, European Proteomics Association (Eupa), Spanish Proteomics Society (Seprot), Netherlands Proteomic Platform (Npp), Japan Human Proteome Organisation (Jhupo), Italian Proteomic Association (Itpa), Portugese Proteomic Association (Rede Procura), Iranian Proteomic Society, Taiwan Proteomic Society (Tps), Austrian Proteomics Society, European Proteomics Association, British Mass Spectrometry Society, Belgian Mass Spectrometry Society, Danish Mass Spectrometry Society

Track: 12Proteomics and its Research

Proteins provide most of themolecularmachinery of cells. Many areenzymesor subunits of enzymes. Other proteins play structural or mechanical roles, such as those that form the struts and joints of the cytoskeleton. Eachproteinis linear polymers built ofamino acids.

Relevant Conferences: Proteomics Conferences | Proteomics and Molecular Medicine Conferences | Proteomics Conferences 2018 | Proteomics Conferences USA

12th International Conference on Advancements in Bioinformatics and Drug Discovery November 26-27, 2018 Dublin, Ireland; Nordic Proteomics Conference April 18-20, 2018 Bergen, Norway; XII Eupa Congress – Translating genomes into biological functions June 16-20, 2018 Santiago de Compostela, Spain; 43rd FEBS 2018 Congress July 7-12, 2018 Prague, Czech Republic; Human Proteome Organization September 30 October 03 2018 Orlando, USA; Annual Swiss Proteomics Meeting 2018 April 19-20, 2018 Montreux, Switzerland; 22nd International Mass Spectrometry Conference August 26-31, 2018 Florence, Italy; 12th International Conference and Expo on Proteomics and Molecular Medicine November 26-28, 2018 Dublin, Ireland

Relevant Societies: Australian and New Zealand Mass Spectrometry Society, Indiana Proteomics Consortium, Proteome Society, European federation of biotechnology, Australasian Proteomics Society, Association for Molecular Pathology, Molecular and Cellular Cognition Society, Hong Kong Society For Molecular Diagnostic Sciences Limited, Biochemical Society, Society for Molecular Biology & Evolution, The French Society for Biochemistry and Molecular Biology, The German Society for Biochemistry and Molecular Biology, Molecular Biology Society of Japan, Society of Nuclear Medicine and Molecular Imaging

Proteomics attribute to the study of proteomes, but is also used to characterize the techniques used to determine the complete set of proteins of an organism or system, such as protein purification and MS. Proteomics is a developing field that has been deeply enabled by the human genome project. Proteins which are the products of genes, the machinery of the cells in our bodies. When genes are disturbed, the proteins are also damaged. When pathogens infect us, causing disease, proteins play a major role in signaling the presence & ridding us of these invaders. Almost every process which that occurs in our cells from the metabolization of clean sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to distinguish & quantify as many proteins as possible likewise Molecular Medicine promotes the understanding of biological mechanism of disease at the cellular and molecular levels for better diagnoses, treatment, and prevention of disease. Proteomics plays an important role in medical research and molecular medicine, such as in drug discovery and diagnostics, because of the link between proteins, genes and diseases, and it is considered to be the next step in modern biology.

There are numerous advances in this proteomics innovation, especially in the field of sub-atomic science. New proteomics and genomics advancements and creations could be utilized for ailment particular biomarker revelation and to screen tolerant reaction to the treatment. Proteomics might likewise set up new, atomic order of the malady. Applying genomic and proteomic strategies to body liquids (serum, cerebrospinal liquid, pee, and so on.) and tissue concentrates would put profitable goal diagnostic force in the hands of the clinician however approval of those techniques is an imperative issue. The quick extension of the analytic apparatuses taking into account advancements in proteomic and genomic advances can be essential for the improvement of customized solution. As a science that studies interactions between the molecular components that carry out the various biological processes in living cells, an important idea in molecular biology states that information flow in organisms follows a one-way street: Genes are transcribed into RNA, and RNA is translated into proteins.

Why Dublin, Ireland?

Europe is one such region which encompasses the major share of the Proteomics and molecular medicine research which is mainly on ovarian cancer biomarker research. Dublin being one of the most advanced European economies is bound to hold the chief share in Europes Proteomics and molecular medicine market. Further as EU expands the research, export and trading relations are bound to enhance.

The globalproteomics marketis expected to reach over USD 24.8 billion by 2024 according to a new report by Grand View Research, Inc. The introduction of technology-enabled proteomics products is one of the high-impact rendering drivers for the proteomics market growth. These products find extensive applications in drug discovery, diagnostic services, and many other research areas. The increasing market penetration of these technologies, such as ESI-LC-MS (electrospray ionization liquid chromatography mass spectrometry), is expected to serve as a driver of this market.

Proteomics Market By Product, USD Million, 2013 – 2024

Theeurope molecular diagnostics marketis expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth.

Molecular medicine, diagnostic market by application, 2013-2024USD Million

Proteomics Congress 2017

Conference Series llc LTDtakes a great pride in announcing the 9thInternational Conference & Expo on Proteomics and Molecular Medicine(Proteomics Congress 2017) which was held in Paris, France, during 13-15 November, 2017.

Proteomics Congress 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics and molecular medicine. The extremely illustrious conference hosted byConference Series llc LTDwas marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 30 countries around the world.

The conference aimed a parallel rail with theme Novel Advancements in Proteomics and Molecular Medicine. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Mass spectrometry in Proteome Research, Protein Expression and Analysis, Proteomics from Discovery to Function, Molecular Medicine and Diagnostics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Molecular Medicine, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderatorsDr. Oliva Petra from Sanofi Genzyme, USA, Dr. Marwa Eltoweissy, University of Gttingen, Germany for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists,Boris Zaslavsky, Cleveland Diagnostics, USA;Bin Huang, Kaohsiung Medical University, Taiwan;Judit Ovdi, Hungarian Academy of Sciences, Hungary;Jarrod A Marto, Harvard Medical School, USA; Magnus S Magnusson, University of Iceland, Iceland; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series llc LTDis prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions, workshops and special sessions in a diversified and variegate manner to make this conference an enviable artifact.

Conference Series llc LTDoffers its heartfelt appreciation to the exhibitor Proteintech, collaborators Instruct Integrating Biology, European Biotechnology Network, Bilkent Genetik Toplulugu, Malaysian Biotechnology Information Center, Swiss Biotech Association & Human Behaviour Laboratory who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

Conference Series llc LTDcongratulates the best poster award winner Dr. Pratibha Sharma, All India Institute of Medical Sciences, India. We would also like to thank Dr. Jarrod A Marto, Harvard Medical School, USA and Dr. Pavlina Dolashka, Bulgarian Academy of Sciences, Bulgaria who supported us by evaluating the posters.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

Conference Series llc LTD9thInternational Conference & Expo on Proteomics and Molecular Medicine would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of theJournal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

After the successful completion of eleven consecutive conferences we are overwhelmed to announce our next upcoming conferences which are going to be held in Europe is the 12thInternational Conference and Expo on Proteomics and Molecular Medicine which is going to be held during November 26-28, 2018 in Dublin, Ireland.

Conference Series llc LTDtakes a great pride in announcing the 7thInternational Conference & Expo on Proteomics(Proteomics Congress 2016) which was held in Rome, Italy, during 24-26 October, 2016.

Proteomics Congress 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world.

The conference aimed a parallel rail with theme Proteomics: An atlas of expression. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Proteomics from Discovery to Function, Mass Spectrometry in Proteome Research, Proteomics for Bioinformatics, Cancer and Clinical proteomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderatorsDr. Marwa Eltoweissy, University of Gttingen, Germany,Dr. Jill Barber, University of Manchester, UK for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists,Boris Zaslavsky, Cleveland Diagnostics, USA;John F Cipollo, Center for Biologics Evaluation and Research-USFDA, USA;Stefan Kempa, Berlin Institute for Medical Systems Biology – MDC Berlin, Germany;Magnus S Magnusson, University of Iceland, Iceland; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series llc LTDis prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions, workshops and special sessions in a diversified and variegate manner to make this conference an enviable artifact.

See the article here:

Proteomics Conferences 2018 | Molecular Medicine Congress …

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Latest Releases:Radiation Safety+ Review and Essentials

The new Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCBs Radiation Safety Certification Examination. This 5 module/7.75 credit coursealso includesa 150 question mock exam lets you assess what you’ve learned!Learn More

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you’re looking to buildyour general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). This 18 module/17 credit course also includesa post-course mock exam lets you assess what you’ve learned!Learn More

View Scientific Abstract Oral and Poster Presentations from SNMMI’s2017 Annual Meeting.Learn More

Access synchronized slides, audio and embedded video from 100 of the most popular sessions from SNMMIs 2017 Annual Meeting.Learn More

SNMMI’s online nuclear medicine review course coversadult and pediatric medicine, PET/CT and nuclear cardiology plus imaging protocols, interpretation and limitation.Learn More

SNMMI/ACNM MRI Case Reviews: AbdominalSNMMI and ACNM have partnered to bring you the first-ever set of online MRI teaching modules as an introduction to interpreting MRI.Learn More

Mid-Winter Meeting CT Case ReviewsThis offering provides a comprehensiveCT Case Reviewfor nuclear medicine professionals. Review and interpret up to 100 CT studies.Learn More

Annual Meeting CT/MRI Case ReviewsRecorded at the Annual Meeting, this online offering provides the opportunity to review and interpret 52 CT studies and 48 MRI case studies.Learn More

Free Journal SAM/CE accessis available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements.Learn more

Fee recently reduced! The PET Online Review Workshop is designed to prepare technologists for the NMTCB’s PET Exam.Learn More

Read the rest here:

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Home | WSU Center for Molecular Medicine and Genetics

Our underlying goal is excellence in molecular biology, molecular medicine, and genetics to increase the understanding, diagnosis, treatment and prevention of human disease.

The Center for Molecular Medicine and Genetics is interdisciplinary by design, built around modern molecular genetics, and comprising basic researchers, physician-scientists, computational scientists, and genetic counselors. Thisassembly of disciplines has lead to a diverse portfolio of projects.

The rest is here:

Home | WSU Center for Molecular Medicine and Genetics

Center for Applied Proteomics and Molecular Medicine

What is Personalized Medicine?

Every individuals disease is different. Personalized medicine strives to provide the right medicine for the right patient with the lowest toxicity. Personalized cancer therapy using proteomics involves molecular profiling of the patients cancer cells to map the susceptible drug targets and thereby guide therapy. Research, like that being done by the Center for Applied Proteomics and Molecular Medicine, provides strategies for personalized treatment with the goal of providing physicians key missing molecular information about the disease in each of their patients and improving the quality of life for patients.

The Center for Applied Proteomics and Molecular Medicines mission is to: a) create new technologies and make basic science discoveries in the field of disease pathogenesis b) apply these discoveries and technologies to create and implement strategies for disease prevention, early diagnosis and individualized therapy. The primary emphasis of our disease research is cancer, but new technologies developed in the center are being applied to a number of important human diseases including cardiovascular disease, diabetes, and obesity, as well as liver, ocular, neurodegenerative and infectious diseases.

The Scientists at George Mason University have developed a nanotechnology that for the first time can measure a sugar molecule in urine that identifies tuberculosis with high sensitivity and specificity, setting the stage for a rapid, highly accurate and far less-invasive urine test of the disease that could potentially prove to be the difference between life and death in many underdeveloped parts of the world.The international team led by George Masons Alessandra Luchini and Lance Liotta report in Science Translational Magazine that a sugar molecule called LAM, which comes from the surface of the tuberculosis bacteria, can be measured in the urine of all patients with active tuberculosis regardless of whether they have a simultaneous infection with another pathogen (e.g. HIV). The more severe the disease, the higher the sugar concentration in the urine, said Luchini, an associate professor in Masons College of Science.Current methods of detection skin tests, blood tests and chest X-rays are often very expensive and not always available in rural settings in lesser developed parts of the world. Urine is considered an ideal body fluid for a TB test because it can be easily and noninvasively collected.We can measure now what could never be measured before, said Liotta, co-director of Masons Center for Applied Proteomics and Molecular Medicine.

The Side-Out Metastatic Breast cancer trial was announced at the annual meeting of the American Society of Clinical Oncology (ASCO) and is expected to expand into phase two this month.

ASCO Poster Presentation

The pilot study was the first of its kind to utilize novel protein activation mapping technology along with the genomic fingerprint of cancer as a way to find the most effective treatment. Results indicate that while prior standard chemotherapy failed the 25 women who participated in the 2.5 year pilot study, nearly half of the patients enrolled in the Side-Out trail had at least a 30 percent increase in progression-free survival.

This molecular approach creates opportunities for new therapies. For example, if a breast tumor shares the same protein pathway activation shared with lung cancer, then the drug developed to hit that target for lung cancer can be used now for breast cancer. The pilot study included only FDA-approved drugs currently on the market. Additional studies are expected to fold in new drugs as they become available with experimental drug.

Hear what patients and a treating physician has to say: Funded by Volleyball Tournaments, Breast Cancer Pilot Study Succeeds

Based on the results of this trial, CAPMM and the Side-Out Foundation are expanding this study to a new trial that is set to launch within the next month.

See original here:

Center for Applied Proteomics and Molecular Medicine

Molecular Medicine – Graduate School of Biomedical …

The Department of Molecular Medicine in the Institute of Biotechnology (IBT) was established in 1994 to administer a program to train graduate students at the interface of basic and clinical sciences with an emphasis on biomedical research focused on discovering the molecular mechanisms underlying human disease and to serve as a platform for the development of novel treatment or prevention approaches. To date, our program has awarded over 120 doctoral degrees. Our graduates are placed in top-tier research universities and pharmaceutical companies across the United States and Europe. Our faculty have been successful in securing tens of millions of dollars from private and federal agencies including the National Institutes of Health, the National Science Foundation, and the Department of Defense.

Now also located in the South Texas Research Facility (STRF), we offer a research-oriented, interdisciplinary program of study in the areas of cancer and aging and their prevention. Specific areas of study include: cell (and hormone) signaling, gene expression, epigenetics, cell cycle and checkpoint controls, DNA damage repair and associated stress responses, and regulated protein turnover. Under new leadership, Dr. Tim Huang is expanding our research to include a Systems approach to molecular medicine that offers students an integrated training program spanning molecular and cellular biology, quantitative biology, computational biology, and genomics.

Our goal is to educate and train the next generation of graduate students who will change the face of biomedical research and invent new ways to treat and prevent human diseases.

Molecular Medicine in the News

Graduate School Launches a New Masters in Personalized Molecular Medicine

The Masters program in Personalized Molecular Medicine (PMM) will uniquely position new graduates to join the work force with the skills necessary to participate fully in the next generation of patient-powered research and treatment. The PMM program will train students in current personalized medicine approaches as well as teach students the knowledge and skills required to explore molecular medicine pathways that will be targeted in the future to expand and refine personalized treatment strategies.

For more information, click here.

Dr. Thomas Boyer awarded NIH grants to study uterine fibroids

Thomas G. Boyer, Ph.D., professor of molecular medicine at UT Health San Antonio, has received two related NIH R01 grants to study uterine leiomyomas, also called uterine fibroids.

The first grant was for $1.56 million; the most recent, a five-year award for $3.8 million, was a multi-PI grant to Dr. Boyer and Ayman Al-Hendy, M.D., Ph.D., a professor of obstetrics and gynecology at the University of Illinois at Chicago.

Both awards have been made possible by a productive, ongoing collaboration with Dr. Robert Schenken and his team in the Department of OB/GYN here at UT Health San Antonio, said Dr. Boyer.

For the rest of this story, please click here.

Uncovering clues in BRCA1 breast cancer gene

Dr. Rong Li and his colleagues are changing the paradigm of how BRCA1 suppresses tumors

When Rong Li, Ph.D., transferred his laboratory to UT Health San Antonio, he finally felt he was making real progress in breast cancer research.

I was trained as a molecular biologist, and I studied the fundamental cellular processes in a lab setting, says Li, a professor of molecular medicine who left his faculty position at the University of Virginia in 2007. But I felt unsatisfied because I wanted to connect my lab findings more closely to human health.

At UT Health, he found the opportunity to collaborate with physician scientists, both at the international level and closer to home. UT Health breast oncologists Ismail Jatoi, M.D., and Richard Elledge, M.D., as well as plastic and reconstructive surgeon Dr. Howard Wang, M.D., have offered cross-disciplinary support, and some of their patients donate breast tissue samples for Lis research.

The story is continued here.

Recent Publications with High Impact Factors

Seol JH, Holland C, Li X, Kim C, Li F, Medina-Rivera M, Eichmiller R, Gallardo IF, Finkelstein IJ, Hasty P, Shim EY, Surtees JA, Lee SE. (2018) Distinct roles of XPF-ERCC1 and Rad1-Rad10-Saw1 in replication-coupled and uncoupled inter-strand crosslink repair. Nat Commun. 2018 May 23;9(1):2025. doi:10.1038/s41467-018-04327-0. PubMed PMID: 29795289.

Patel MJ, Tripathy S, De Mukhopadhyay K, Wangjam T, Cabang AB, Morris J, Wargovich MJ. (2018) A Supercritical Co2 Extract of Neem Leaf (A. indica) and its Bioactive Liminoid, Nimbolide, Suppresses Colon Cancer in Preclinical Models by Modulating Pro-inflammatory Pathways. Mol Carcinogenesis. 2018 Apr 26. doi: 10.1002/mc.22832. [Epub ahead of print] PMID: 29697164

Park MJ, Shen H, Spaeth JM, Tolvanen JH, Failor C, Knudtson JF, McLaughlin J, Halder SK, Yang Q, Bulun SE, Al-Hendy A, Schenken RS, Aaltonen LA, Boyer TG. (2018) Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19. J Biol Chem. 2018 Mar 30; 293(13):4870-4882. doi: 10.1074/jbc.RA118.001725. Epub 2018 Feb 13.

Chen H, Shen F, Sherban A, Nocon A, Li Y, Wang H, Xu MJ, Rui X, Han J, Jiang B, Lee D, Li N, Keyhani-Nejad F, Fan JG, Liu F, Kamat A, Musi N, Guarente L, Pacher P, Gao B, Zang M. (2018) DEP domain-containing mTOR-interacting protein suppresses lipogenesis and ameliorates hepatic steatosis and acute-on-chronic liver injury in alcoholic liver disease. Hepatology. 2018 Feb 19. doi: 10.1002/hep.29849. [Epub ahead of print]

Recently Awarded Grants

Early Detection of Castration-Resistant Prostate Cancer by Assessing Interactions Between Circulating Tumor Cells and Accompanying Immune CellsDOD (CDMRP-PCRP), 9/1/18, $915,000Tim Huang, Ph.D., Maria Gaczynska, Ph.D.

Mechanisms of Error Prone Repair of DNA breaksNIH – National Institute of General Medical Sciences, 8/1/18, $1,250,500Sang Eun Lee, Ph.D.

2018 Young Investigator AwardThe Max and Minnie Tomerlin Voelcker Fund, 6/30/2018, $450,000Myron Ignatius, Ph.D.

Combating protein-misfolding diseasesWilliam & Ella Owens Foundation of America, 3/1/18, $100,000Hai Rao, Ph.D.

Hypovitaminosis D promotes MED12-associated genomic instability in uterine fibroidsNIH National Institute of Child Health and Human Development, 2/15/18, $3,819,365Thomas Boyer, Ph.D.

Here is the original post:

Molecular Medicine – Graduate School of Biomedical …

Home | Cellular & Molecular Medicine

Curtis Thorne, PhD, and colleagues published a new study in Developmental Cell describing a simple, scalable method to culture 2D enteroid monolayers that, surprisingly, recapitulates many of the features of in vivo intestinal tissue and can be used for high-throughput microscopy-based experiments. Using this system, they systematically perturb WNT and BMP signals to reveal a core morphogenic circuit that controls proliferation, tissue organization, and cell fate or the intestine.

Go here to see the original:

Home | Cellular & Molecular Medicine

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Latest Releases:Radiation Safety+ Review and Essentials

The new Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCBs Radiation Safety Certification Examination. This 5 module/7.75 credit coursealso includesa 150 question mock exam lets you assess what you’ve learned!Learn More

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you’re looking to buildyour general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). This 18 module/17 credit course also includesa post-course mock exam lets you assess what you’ve learned!Learn More

View Scientific Abstract Oral and Poster Presentations from SNMMI’s2017 Annual Meeting.Learn More

Access synchronized slides, audio and embedded video from 100 of the most popular sessions from SNMMIs 2017 Annual Meeting.Learn More

SNMMI’s online nuclear medicine review course coversadult and pediatric medicine, PET/CT and nuclear cardiology plus imaging protocols, interpretation and limitation.Learn More

SNMMI/ACNM MRI Case Reviews: AbdominalSNMMI and ACNM have partnered to bring you the first-ever set of online MRI teaching modules as an introduction to interpreting MRI.Learn More

Mid-Winter Meeting CT Case ReviewsThis offering provides a comprehensiveCT Case Reviewfor nuclear medicine professionals. Review and interpret up to 100 CT studies.Learn More

Annual Meeting CT/MRI Case ReviewsRecorded at the Annual Meeting, this online offering provides the opportunity to review and interpret 52 CT studies and 48 MRI case studies.Learn More

Free Journal SAM/CE accessis available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements.Learn more

Fee recently reduced! The PET Online Review Workshop is designed to prepare technologists for the NMTCB’s PET Exam.Learn More

See the rest here:

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Center for Applied Proteomics and Molecular Medicine

What is Personalized Medicine?

Every individuals disease is different. Personalized medicine strives to provide the right medicine for the right patient with the lowest toxicity. Personalized cancer therapy using proteomics involves molecular profiling of the patients cancer cells to map the susceptible drug targets and thereby guide therapy. Research, like that being done by the Center for Applied Proteomics and Molecular Medicine, provides strategies for personalized treatment with the goal of providing physicians key missing molecular information about the disease in each of their patients and improving the quality of life for patients.

The Center for Applied Proteomics and Molecular Medicines mission is to: a) create new technologies and make basic science discoveries in the field of disease pathogenesis b) apply these discoveries and technologies to create and implement strategies for disease prevention, early diagnosis and individualized therapy. The primary emphasis of our disease research is cancer, but new technologies developed in the center are being applied to a number of important human diseases including cardiovascular disease, diabetes, and obesity, as well as liver, ocular, neurodegenerative and infectious diseases.

The Scientists at George Mason University have developed a nanotechnology that for the first time can measure a sugar molecule in urine that identifies tuberculosis with high sensitivity and specificity, setting the stage for a rapid, highly accurate and far less-invasive urine test of the disease that could potentially prove to be the difference between life and death in many underdeveloped parts of the world.The international team led by George Masons Alessandra Luchini and Lance Liotta report in Science Translational Magazine that a sugar molecule called LAM, which comes from the surface of the tuberculosis bacteria, can be measured in the urine of all patients with active tuberculosis regardless of whether they have a simultaneous infection with another pathogen (e.g. HIV). The more severe the disease, the higher the sugar concentration in the urine, said Luchini, an associate professor in Masons College of Science.Current methods of detection skin tests, blood tests and chest X-rays are often very expensive and not always available in rural settings in lesser developed parts of the world. Urine is considered an ideal body fluid for a TB test because it can be easily and noninvasively collected.We can measure now what could never be measured before, said Liotta, co-director of Masons Center for Applied Proteomics and Molecular Medicine.

The Side-Out Metastatic Breast cancer trial was announced at the annual meeting of the American Society of Clinical Oncology (ASCO) and is expected to expand into phase two this month.

ASCO Poster Presentation

The pilot study was the first of its kind to utilize novel protein activation mapping technology along with the genomic fingerprint of cancer as a way to find the most effective treatment. Results indicate that while prior standard chemotherapy failed the 25 women who participated in the 2.5 year pilot study, nearly half of the patients enrolled in the Side-Out trail had at least a 30 percent increase in progression-free survival.

This molecular approach creates opportunities for new therapies. For example, if a breast tumor shares the same protein pathway activation shared with lung cancer, then the drug developed to hit that target for lung cancer can be used now for breast cancer. The pilot study included only FDA-approved drugs currently on the market. Additional studies are expected to fold in new drugs as they become available with experimental drug.

Hear what patients and a treating physician has to say: Funded by Volleyball Tournaments, Breast Cancer Pilot Study Succeeds

Based on the results of this trial, CAPMM and the Side-Out Foundation are expanding this study to a new trial that is set to launch within the next month.

More:

Center for Applied Proteomics and Molecular Medicine

Cryptocurrency News: What You Need to Know This Week

Cryptocurrency News
Cryptocurrencies traded sideways since our last report on cryptos. However, I noticed something interesting when playing around with Yahoo! Finance’s cryptocurrency screener: There are profitable pockets in this market.

Incidentally, Yahoo’s screener is far superior to the one on CoinMarketCap, so if you’re looking to compare digital assets, I highly recommend it.

But let’s get back to my epiphany.

In the last month, at one point or another, most crypto assets on our favorites list saw double-digit increases. It’s true that each upswing was followed by a hard crash, but investors who rode the trend would have made a.

The post Cryptocurrency News: What You Need to Know This Week appeared first on Profit Confidential.

View original post here:

Cryptocurrency News: What You Need to Know This Week

Cryptocurrency Price Forecast: Trust Is Growing, But Prices Are Falling

Trust Is Growing…
Before we get to this week’s cryptocurrency news, analysis, and our cryptocurrency price forecast, I want to share an experience from this past week. I was at home watching the NBA playoffs, trying to ignore the commercials, when a strange advertisement caught my eye.

It followed a tomato from its birth on the vine to its end on the dinner table (where it was served as a bolognese sauce), and a diamond from its dusty beginnings to when it sparkled atop an engagement ring.

The voiceover said: “This is a shipment passed 200 times, transparently tracked from port to port. This is the IBM blockchain.”

Let that sink in—IBM.

The post Cryptocurrency Price Forecast: Trust Is Growing, But Prices Are Falling appeared first on Profit Confidential.

View post:

Cryptocurrency Price Forecast: Trust Is Growing, But Prices Are Falling

Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More

Ripple vs SWIFT: The War Begins
While most criticisms of XRP do nothing to curb my bullish Ripple price forecast, there is one obstacle that nags at my conscience. Its name is SWIFT.

The Society for Worldwide Interbank Financial Telecommunication (SWIFT) is the king of international payments.

It coordinates wire transfers across 11,000 banks in more than 200 countries and territories, meaning that in order for XRP prices to ascend to $10.00, Ripple needs to launch a successful coup. That is, and always has been, an unwritten part of Ripple’s story.

We’ve seen a lot of progress on that score. In the last three years, Ripple wooed more than 100 financial firms onto its.

The post Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More appeared first on Profit Confidential.

See the article here:

Ripple Price Forecast: XRP vs SWIFT, SEC Updates, and More

The Epic Relation Between Bitcoin and the Stock Market

Bitcoin Prices Are Less Independent Than You Think
Inside the world of cryptocurrencies, some truths go unquestioned: 1) centralization is terrible, 2) fixed money supplies are great, 3) cryptocurrencies are uncorrelated from stocks.

The last “truth” is now in question.

Many analysts, myself included, have raised questions about Bitcoin following the stock market before, but none of us made the case as strongly as Forbes contributor Clem Chambers.

Chambers recently used intraday trade charts to show that Bitcoin prices often follow the same patterns as the Dow Jones Index. (Source: “.

The post The Epic Relation Between Bitcoin and the Stock Market appeared first on Profit Confidential.

Read the rest here:

The Epic Relation Between Bitcoin and the Stock Market

Ripple Price Prediction: xRapid Shows Success, But SEC Still Holds Power

XRP Prices Hang in the Balance
Ripple bears like to claim that XRP “serves no purpose” in its technology, but recent success with the “xRapid” software says otherwise. That—plus the continual “Is XRP a security?” debate—drove Ripple prices round and round in circles last week.

I see these two forces working in opposite directions.

Investors should be happy that xRapid is providing genuine benefits to businesses that dared to take a chance on XRP. But does it matter if the U.S. Securities & Exchange Commission (SEC) designates XRP a security?
xRapid Success
For the uninitiated, Ripple has multiple offerings. One is “xCurrent,” a.

The post Ripple Price Prediction: xRapid Shows Success, But SEC Still Holds Power appeared first on Profit Confidential.

Here is the original post:

Ripple Price Prediction: xRapid Shows Success, But SEC Still Holds Power

Cryptocurrency News: This Week on Bitfinex, Tether, Coinbase, & More

Cryptocurrency News
On the whole, cryptocurrency prices are down from our previous report on cryptos, with the market slipping on news of an exchange being hacked and a report about Bitcoin manipulation.

However, there have been two bright spots: 1) an official from the U.S. Securities and Exchange Commission (SEC) said that Ethereum is not a security, and 2) Coinbase is expanding its selection of tokens.

Let’s start with the good news.
SEC Says ETH Is Not a Security
Investors have some reason to cheer this week. A high-ranking SEC official told attendees of the Yahoo! All Markets Summit: Crypto that Ethereum and Bitcoin are not.

The post Cryptocurrency News: This Week on Bitfinex, Tether, Coinbase, & More appeared first on Profit Confidential.

Original post:

Cryptocurrency News: This Week on Bitfinex, Tether, Coinbase, & More

Cryptocurrency News: Looking Past the Bithumb Crypto Hack

Another Crypto Hack Derails Recovery
Since our last report, hackers broke into yet another cryptocurrency exchange. This time the target was Bithumb, a Korean exchange known for high-flying prices and ultra-active traders.

While the hackers made off with approximately $31.5 million in funds, the exchange is working with relevant authorities to return the stolen tokens to their respective owners. In the event that some is still missing, the exchange will cover the losses. (Source: “Bithumb Working With Other Crypto Exchanges to Recover Hacked Funds,”.

The post Cryptocurrency News: Looking Past the Bithumb Crypto Hack appeared first on Profit Confidential.

See the original post:

Cryptocurrency News: Looking Past the Bithumb Crypto Hack

Ethereum Price Forecast: Big Corporate Moves Could Bolster ETH Prices

Crypto Rally Slows Down
As I write this report, cryptocurrency prices are in the middle of a vicious tug of war between the bulls and the bears. And the bears are winning right now.

Most, if not all, of our favorite cryptocurrencies trended down over the last seven days, erasing the progress they made in earlier weeks.

Short-term volatility is completely overtaking the market, making it tough for existing holders of crypto assets.

But…

If you’re someone who is looking to enter the market, a sell-off is exactly the right time. How many times have I heard investors say, “If I had bought Bitcoin two years ago, I would have made [insert insane profits.

The post Ethereum Price Forecast: Big Corporate Moves Could Bolster ETH Prices appeared first on Profit Confidential.

Read this article:

Ethereum Price Forecast: Big Corporate Moves Could Bolster ETH Prices

Cryptocurrency News: Bitcoin ETFs, Andreessen Horowitz, and Contradictions in Crypto

Cryptocurrency News
This was a bloody week for cryptocurrencies. Everything was covered in red, from Ethereum (ETH) on down to the Basic Attention Token (BAT).

Some investors claim it was inevitable. Others say that price manipulation is to blame.

We think the answers are more complicated than either side has to offer, because our research reveals deep contradictions between the price of cryptos and the underlying development of blockchain projects.

For instance, a leading venture capital (VC) firm launched a $300.0-million crypto investment fund, yet liquidity continues to dry up in crypto markets.

Another example is the U.S. Securities and Exchange Commission’s.

The post Cryptocurrency News: Bitcoin ETFs, Andreessen Horowitz, and Contradictions in Crypto appeared first on Profit Confidential.

View original post here:

Cryptocurrency News: Bitcoin ETFs, Andreessen Horowitz, and Contradictions in Crypto

Cryptocurrency News: XRP Validators, Malta, and Practical Tokens

Cryptocurrency News & Market Summary
Investors finally saw some light at the end of the tunnel last week, with cryptos soaring across the board. No one quite knows what kicked off the rally—as it could have been any of the stories we discuss below—but the net result was positive.

Of course, prices won’t stay on this rocket ride forever. I expect to see a resurgence of volatility in short order, because the market is moving as a single unit. Everything is rising in tandem.

This tells me that investors are simply “buying the dip” rather than identifying which cryptos have enough real-world value to outlive the crash.

So if you want to know when.

The post Cryptocurrency News: XRP Validators, Malta, and Practical Tokens appeared first on Profit Confidential.

Here is the original post:

Cryptocurrency News: XRP Validators, Malta, and Practical Tokens

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Latest Releases:Radiation Safety+ Review and Essentials

The new Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCBs Radiation Safety Certification Examination. This 5 module/7.75 credit coursealso includesa 150 question mock exam lets you assess what you’ve learned!Learn More

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you’re looking to buildyour general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). This 18 module/17 credit course also includesa post-course mock exam lets you assess what you’ve learned!Learn More

View Scientific Abstract Oral and Poster Presentations from SNMMI’s2017 Annual Meeting.Learn More

Access synchronized slides, audio and embedded video from 100 of the most popular sessions from SNMMIs 2017 Annual Meeting.Learn More

SNMMI’s online nuclear medicine review course coversadult and pediatric medicine, PET/CT and nuclear cardiology plus imaging protocols, interpretation and limitation.Learn More

SNMMI/ACNM MRI Case Reviews: AbdominalSNMMI and ACNM have partnered to bring you the first-ever set of online MRI teaching modules as an introduction to interpreting MRI.Learn More

Mid-Winter Meeting CT Case ReviewsThis offering provides a comprehensiveCT Case Reviewfor nuclear medicine professionals. Review and interpret up to 100 CT studies.Learn More

Annual Meeting CT/MRI Case ReviewsRecorded at the Annual Meeting, this online offering provides the opportunity to review and interpret 52 CT studies and 48 MRI case studies.Learn More

Free Journal SAM/CE accessis available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements.Learn more

Fee recently reduced! The PET Online Review Workshop is designed to prepare technologists for the NMTCB’s PET Exam.Learn More

See the original post here:

Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Ripple Price Forecast: Has the Much-Awaited XRP Rally Started?

XRP Prices: Patience Is Warranted
2017 was a great year for investors, where the market environment was characterized by a constant barrage of new all-time highs, low volatility, and a number of high-flying sectors taking center stage. 2018 is turning out to be a whole different beast; a market correction has currently gripped the markets and all the high-flying sectors that led the market late last year are currently correcting.

Cryptocurrencies were by far the best-performing asset class last year, and it shouldn’t be too shocking that they are the worst-performing asset class this year. For example, Ripple staged an epic advance in 2017, tacking on an incredible 3,216.67%.

The post Ripple Price Forecast: Has the Much-Awaited XRP Rally Started? appeared first on Profit Confidential.

View original post here:

Ripple Price Forecast: Has the Much-Awaited XRP Rally Started?